The role of inflammatory cytokines in diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2007091048PMID 18256353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-α stimulation, and effects of a phosphodiesterase inhibitor

  2008cited by this paper
• Agents in development for the treatment of diabetic nephropathy

  2008cited by this paper
• Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.

  2007cited by this paper
• Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats

  2007cited by this paper
• Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.

  2007cited by this paper
• Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade

  2007cited by this paper
• Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury.

  2007cited by this paper
• Renal Pro-Inflammatory Cytokine Gene Expression in Diabetic Nephropathy: Effect of Angiotensin-Converting Enzyme Inhibition and Pentoxifylline Administration

  2007cited by this paper
• Cytokine gene polymorphism and progression of renal and cardiovascular diseases.

  2007cited by this paper
• Inflammatory mechanisms of diabetic complications

  2007cited by this paper
• Aberrant activation profile of cytokines and mitogen‐activated protein kinases in type 2 diabetic patients with nephropathy

  2007cited by this paper
• Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link?

  2007cited by this paper
• CYCLO‐OXYGENASE‐2 INHIBITION ATTENUATES THE PROGRESSION OF NEPHROPATHY IN UNINEPHRECTOMIZED DIABETIC RATS

  2007cited by this paper
• Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats.

  2007cited by this paper
• Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.

  2007cited by this paper
• Inflammation and diabetic nephropathy

  2006cited by this paper
• Inflammatory process in type 2 diabetes: The role of cytokines.

  2006cited by this paper
• Inflammation and insulin resistance.

  2006cited by this paper
• Elevated intravitreal interleukin-6 levels in patients with proliferative diabetic retinopathy.

  2006cited by this paper
• Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.

  2006cited by this paper
• Leukocyte recruitment and vascular injury in diabetic nephropathy.

  2006cited by this paper
• Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial.

  2006cited by this paper
• Hyperfiltration, nitric oxide, and diabetic nephropathy

  2006cited by this paper
• Role of TGF-beta in pathogenesis of diabetic nephropathy.

  2006cited by this paper
• Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy

  2006cited by this paper
• Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.

  2006cited by this paper
• Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy

  2006cited by this paper
• Cytokine gene polymorphism in human disease: on-line databases, Supplement 3

  2006cited by this paper
• Genetics of diabetes and its complications.

  2006cited by this paper
• Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.

  2006cited by this paper
• Inflammatory Process in Type 2 Diabetes

  2006cited by this paper
• Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy.

  2006cited by this paper
• Emerging drugs for diabetic nephropathy

  2005cited by this paper
• Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes.

  2005cited by this paper
• Molecular screening and association analyses of the interleukin 6 receptor gene variants with type 2 diabetes, diabetic nephropathy, and insulin sensitivity.

  2005cited by this paper
• Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial.

  2005cited by this paper
• Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation

  2005cited by this paper
• Protective Effects of Angiotensin II Interruption: Evidence for Antiinflammatory Actions

  2005cited by this paper
• Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease.

  2005cited by this paper
• Comparison of the Effect of Pentoxifylline and Captopril on Proteinuria in Patients with Type 2 Diabetes mellitus

  2005cited by this paper
• Pathogenetic mechanisms of diabetic nephropathy.

  2005cited by this paper
• Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.

  2005cited by this paper
• Agents in development for the treatment of diabetic nephropathy

  2005cited by this paper
• The next generation of diabetic nephropathy therapies: an update.

  2005cited by this paper
• Role of inflammation in diabetic complications.

  2005cited by this paper
• Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

  2005cited by this paper
• Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

  2005cited by this paper
• The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes.

  2005cited by this paper
• Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.

  2005cited by this paper
• Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.

  2005cited by this paper
• Polymorphisms in Interleukin-1β and Interleukin-1 Receptor Antagonist Genes Are Associated with Kidney Failure in Korean Patients with Type 2 Diabetes mellitus

  2004cited by this paper
• NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.

  2004cited by this paper
• Inflammation: the link between insulin resistance, obesity and diabetes.

  2004cited by this paper
• Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats.

  2004cited by this paper
• Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.

  2004cited by this paper
• Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats

  2004cited by this paper
• Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.

  2004cited by this paper
• The involvement of growth hormone (GH), insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in diabetic kidney disease.

  2004cited by this paper
• Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

  2004cited by this paper
• Type 2 diabetes mellitus: a disease of the innate immune system? An update

  2004cited by this paper
• Pentoxifylline Ameliorates Renal Tumor Necrosis Factor Expression, Sodium Retention, and Renal Hypertrophy in Diabetic Rats

  2004cited by this paper
• The global burden of chronic diseases: overcoming impediments to prevention and control.

  2004cited by this paper
• Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure.

  2004cited by this paper
• Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus.

  2004cited by this paper
• Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.

  2004cited by this paper
• Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

  2003cited by this paper
• Role of Neuropoietic Cytokines in Development and Progression of Diabetic Polyneuropathy: From Glucose Metabolism to Neurodegeneration

  2003cited by this paper
• Inflammation and insulin resistance.

  2003cited by this paper
• Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.

  2003cited by this paper
• Selective regulation of intercellular adhesion molecule‐1 expression by interleukin‐18 and interleukin‐12 on human monocytes

  2003cited by this paper
• Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.

  2003cited by this paper
• Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes.

  2003cited by this paper
• Identification of novel SNPs in the interleukin 6 receptor gene (IL6R)

  2003cited by this paper
• Tumor Necrosis Factor-&agr; Promotes Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis by Direct and Autocrine Mechanisms

  2003cited by this paper
• Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

  2003cited by this paper
• Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.

  2003cited by this paper
• Adipokines, inflammation, and the endothelium in diabetes

  2003cited by this paper
• Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians.

  2003cited by this paper
• Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.

  2003cited by this paper
• Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes.

  2003cited by this paper
• Six novel ATM mutations in Italian patients with classical ataxia‐telangiectasia

  2003cited by this paper
• Combination of Pentoxifylline with Angiotensin Converting Enzyme Inhibitors Produces an Additional Reduction in Microalbuminuria in Hypertensive Type 2 Diabetic Patients

  2003cited by this paper
• Diagnostic criteria for polymyositis and dermatomyositis

  2003cited by this paper
• CHAPTER 1 – The cytokines: an overview

  2003cited by this paper
• Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)

  2003cited by this paper
• Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults.

  2003cited by this paper
• IFNgamma induces functional chemokine receptor expression in human mesangial cells.

  2002cited by this paper
• Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice.

  2002cited by this paper
• Interleukin‐6 polymorphism (–634C/G) in the promotor region and the progression of diabetic nephropathy in Type 2 diabetes

  2002cited by this paper
• Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension.

  2002cited by this paper
• IFNγ induces functional chemokine receptor expression in human mesangial cells

  2002cited by this paper
• Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFα monoclonal antibody and by pentoxiphylline

  2001cited by this paper
• Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes.

  2001cited by this paper
• Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy.

  2001cited by this paper
• Prevention of end-stage renal disease due to type 2 diabetes.

  2001cited by this paper
• Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure.

  2001cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• Role of macrophages in the pathogenesis of diabetic nephropathy.

  2001cited by this paper
• Pro-inflammatory cytokines and adipose tissue

  2001cited by this paper
• Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.

  2000cited by this paper

• Guideline-Directed Medical Therapy for Diabetic Kidney Disease: Advances in Primary and Secondary Prevention.

  2026cites this paper
• Inflammatory markers associated with albuminuria and early atherosclerosis in type 2 diabetic kidney disease: a cross-sectional study

  2026cites this paper
• Urinary microenvironment-degradable nanocapsules for traceable therapy of diabetic nephropathy

  2026cites this paper
• Glycated CD59: an emerging biomarker of diabetic nephropathy associated with microalbuminuria, tubular damage, and complement activation

  2026cites this paper
• Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies

  2026cites this paper
• Mechanisms of Inflammation-Fibrosis in Diabetic Nephropathy and Intervention Strategies of Traditional Chinese and Western Medicine

  2026cites this paper
• Characterizing the tuberculosis and type 2 diabetes mellitus comorbidity in a South African cohort using untargeted GCxGC-TOFMS metabolomics

  2026influential citation
• Integrative Analysis on the Urinary Proteome of Diabetic Kidney Disease, with an Emphasis on Extracellular Matrix Proteins

  2026cites this paper
• Reactive oxygen species scavenging hydrogel for wound healing in diabetic mice

  2025cites this paper
• Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesity

  2025cites this paper
• Capilliposide A attenuates diabetic nephropathy via modulation of NF-κB/TLR4 and apoptotic pathways

  2025cites this paper
• REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy

  2025cites this paper
• Modulation of immunological cytokines and miRNA expression by L-carnitine in patients with type 2 diabetes mellitus

  2025cites this paper
• Exploring the role of pentoxifylline as a renal protector in diabetic kidney disease: a comprehensive review

  2025cites this paper
• Hyperglycaemia-Induced Nephropathy is Prevented by Resveratrol and Pioglitazone Co-Administration in Type-2 Diabetic Male Wistar Rats

  2025cites this paper
• Association between serum tumor markers and diabetic nephropathy in type 2 diabetes patients: a cross-sectional survey in Western China

  2025cites this paper
• The ameliorative effect of lycopene and grape seed proanthocyanidins extract against streptozotocin-induced diabetic nephropathy in rats

  2025cites this paper
• Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and Dimerization

  2025cites this paper
• Neutrophil Percentage to Albumin Ratio is Associated With Diabetic Kidney Disease in Community Cohorts: A More In‐Depth Insight Incorporating Machine Learning

  2025cites this paper
• Diabetic peripheral neuropathy as measured using a point‐of‐care sural nerve conduction device is associated with a faster decline in renal function in patients with type 2 diabetes

  2025cites this paper
• FABP4 inhibition protects renal tubular cells and ameliorates renal inflammation in diabetic kidney disease.

  2025cites this paper
• Aspirin-responsive gene switch regulating therapeutic protein expression

  2025influential citation
• Semaglutide in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights

  2025cites this paper
• A simple and effective hydrogel dressing for advanced management of full-thickness skin wound by multi-functional strategies

  2025cites this paper
• The Partial Mediating Role of Arterial Stiffness in the Association Between Systemic Inflammation and Declining Renal Function in Type 2 Diabetes Mellitus: A Cross-Sectional Study

  2025cites this paper
• Role of Interleukins in Type 1 and Type 2 Diabetes

  2025cites this paper
• Avaliação da Doença Renal em pacientes com Diabetes Mellitus Tipo 1 Atendidos em Ambulatório de Endocrinologia de Serviço Terciário

  2025cites this paper
• Interleukin 6: friend or foe in diabetic nephropathy?

  2025influential citation
• A review of the literature on obesity-related chronic kidney disease: a molecular description of gene susceptibility to polymorphisms, noncoding RNAs, and pathophysiology

  2025influential citation
• Celastrol protects against diabetic nephropathy by modulating immune-related pathways: a bioinformatics and experimental validation.

  2025cites this paper
• Network Pharmacology, Molecular Dynamics Simulation, and Biological Validation Insights into the Potential of Ligustri Lucidi Fructus for Diabetic Nephropathy

  2025cites this paper
• Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease

  2025cites this paper
• DNA methylation in chronic kidney disease

  2025cites this paper
• Targeting α‑Klotho Protein by Agmatine and Pioglitazone Is a New Avenue against Diabetic Nephropathy.

  2025cites this paper
• Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress

  2025cites this paper
• Association Between Incident Chronic Kidney Disease and Body Size Phenotypes in Apparently Healthy Adults: An Observational Study Using the Korean National Health and Nutrition Examination Survey (2019–2021)

  2025cites this paper
• Investigation of the action mechanism of Madhumega kudineer formulation against Diabetic Nephropathy by network pharmacology, molecular docking and dynamics strategies

  2025cites this paper
• Network pharmacology and experimental validation to investigate the mechanism of action of Zhilong Huoxue Tongyu capsule in the prevention and treatment of diabetic cardiomyopathy

  2025cites this paper
• Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway

  2024cites this paper
• Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice.

  2024cites this paper
• Plant-Derived Bioactive Molecules in the Management of Diabetic Neuropathy: Insights and Future Prospects

  2024cites this paper
• IL-6 and diabetic kidney disease

  2024cites this paper
• Comparison of complete blood count parameters in different severity of proteinuria among patients with type 2 diabetes mellitus

  2024cites this paper
• Research progress of gut microbiome and diabetic nephropathy

  2024cites this paper
• Alogliptin attenuates STZ-induced diabetic nephropathy in rats through the modulation of autophagy, apoptosis, and inflammation pathways: Targeting NF-κB and AMPK/mTOR pathway.

  2024cites this paper
• Protective effects of Sulforaphene on kidney damage and gut dysbiosis in high-fat diet plus streptozotocin-induced diabetic mice.

  2024cites this paper
• El papel de la ferroptosis en la enfermedad renal diabética

  2024cites this paper
• Bioinformatics reveals the pathophysiological relationship between diabetic nephropathy and periodontitis in the context of aging

  2024cites this paper
• Effects of Spirulina platensis microalgae on renal function and antioxidant defence in rats with streptozotocin-induced diabetes

  2024cites this paper
• Cytokine signalling in formation of neutrophil extracellular traps: Implications for health and diseases.

  2024cites this paper
• Astaxanthin Mitigates Streptozotocin Induced Diabetic Nephropathy, Targeting HMGB1, TLR4 and NF κB

  2024cites this paper
• Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway.

  2024cites this paper
• Observation of neutrophil extracellular traps in the development of diabetic nephropathy using diabetic murine models

  2024cites this paper
• Factors Involved in the Development of Diabetic Kidney Disease in Patients With Slowly Progressive Type 1 Diabetes Mellitus: A Retrospective Cohort Study

  2024cites this paper
• Roux-en-Y gastric bypass alleviates kidney inflammation and improves kidney function in db/db mice by activating TLCA/TGR5 pathway.

  2024cites this paper
• Integrating transcriptomics, metabolomics, and network pharmacology to investigate multi-target effects of sporoderm-broken spores of Ganoderma lucidum on improving HFD-induced diabetic nephropathy rats

  2024cites this paper
• CXCL5 inhibition improves kidney function by protecting renal tubular epithelial cells in diabetic kidney disease.

  2024cites this paper
• Ethyl Acetate Fractions of Salvia miltiorrhiza Bunge (Danshen) Crude Extract Modulate Fibrotic Signals to Ameliorate Diabetic Kidney Injury

  2024cites this paper
• Impact of hyperglycemia on immune cell function: a comprehensive review

  2024cites this paper
• The antioxidant, anti-inflammatory, and anti-apoptotic effects of sesamin against cisplatin-induced renal and testicular toxicity in rats

  2024cites this paper
• Asiaticoside improves diabetic nephropathy by reducing inflammation, oxidative stress, and fibrosis: An in vitro and in vivo study

  2024cites this paper
• Diabetes Mellitus as a Risk Factor for Spontaneous Preterm Birth in Women with a Short Cervix after Ultrasound-Indicated Cerclage

  2024cites this paper
• Food-derived bioactive peptides with anti-hyperuricemic activity: A comprehensive review.

  2024cites this paper
• Evolution and global research trends of immunity in diabetic nephropathy: a bibliometric and visual analysis from 2004 to 2023

  2024cites this paper
• A Quest for Potential Role of Vitamin D in Type II Diabetes Mellitus Induced Diabetic Kidney Disease.

  2024cites this paper
• Oleuropein Supplementation Ameliorates Long-Course Diabetic Nephropathy and Diabetic Cardiomyopathy Induced by Advanced Stage of Type 2 Diabetes in db/db Mice

  2024cites this paper
• Agmatine ameliorates diabetes type 2-induced nephropathy in rats

  2024cites this paper
• (+)-Catechin ameliorates diabetic nephropathy injury by inhibiting endoplasmic reticulum stress-related NLRP3-mediated inflammation.

  2024cites this paper
• Role of triggering receptor expressed on myeloid cells-1 in kidney diseases: A biomarker and potential therapeutic target

  2024cites this paper
• Cytokine levels in Type-2 Diabetes Mellitus (T2DM) Patients with Asymptomatic Bacteriuria (ASB) in Northern Andhra Pradesh

  2024cites this paper
• Pentraxin-3 and Interleukin-18: Potential Biomarkers for the Early Diagnosis and Severity Prediction of Diabetic Foot Ulcer

  2024cites this paper
• Antidiabetic Evaluation of Kigelia pinnata Root Bark Extract in Streptozotocin-Induced Type-2 Diabetes Model of Rats

  2024cites this paper
• Examining B-cell dynamics and responsiveness in different inflammatory milieus using an agent-based model

  2024cites this paper
• Novel Biomarkers for the diagnosis of diabetic nephropathy

  2024influential citation
• Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model.

  2024cites this paper
• Renoprotective Potency of Sitagliptin versus Pioglitazone in Type 2 Diabetic Patients: Impact on LncMIAT

  2023cites this paper
• Renal protective effect of ellipticine against streptozotocin induced diabetic nephropathy in rats via suppression of oxidative stress and inflammatory mediator

  2023cites this paper
• The investigation of the effects of monosodium glutamate on healthy rats and rats with STZ‐induced diabetes

  2023cites this paper
• Magnesium Enhances the Hepatorenal Protective Effects of <i>Lippia multiflora</i> Aqueous Leaves Extract in Streptozotocin-Diabetic Rats

  2023cites this paper
• Quantitative proteomics combined with network pharmacology analysis unveils 1 the biological basis of Schisandrin B in treating diabetic nephropathy

  2023cites this paper
• Rosa laevigata Michx. Polysaccharide Ameliorates Diabetic Nephropathy in Mice through Inhibiting Ferroptosis and PI3K/AKT Pathway-Mediated Apoptosis and Modulating Tryptophan Metabolism

  2023cites this paper
• Insulin Resistance and Insulin Handling in Chronic Kidney Disease.

  2023cites this paper
• Quantitative proteomics combined with network pharmacology analysis unveils 1 the biological basis of Schisandrin B in treating diabetic nephropathy

  2023cites this paper
• Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice.

  2023cites this paper
• Protective effect of paeoniflorin in diabetic nephropathy: A preclinical systematic review revealing the mechanism of action

  2023cites this paper
• Short‐term function and immune‐protection of microencapsulated adult porcine islets with alginate incorporating CXCL12 in healthy and diabetic non‐human primates without systemic immune suppression: A pilot study

  2023cites this paper
• Interleukin-6 and Epidermal Growth Factor as non-invasive biomarkers of progression in chronic glomerulonephritis.

  2023cites this paper
• Effects of oleanolic acid administration on renal NF-kB, IL-18, IL-6, YKL-40, and KIM-1 in experimental diabetic rats

  2023influential citation
• The Role of Monocyte Chemoattractant Protein-1 (MCP-1) in Diabetic Kidney Disease

  2023cites this paper
• Increased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy

  2023cites this paper
• Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes

  2023cites this paper
• Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis.

  2023cites this paper
• Pathophysiology of diabetic kidney disease and autophagy: A review

  2023influential citation
• An Investigation into the Effects of Ubiquinone on Inflammation, Diabetic Myopathy and Endotheliopathy, and CBC Parameters in Diabetic Rats

  2023cites this paper
• An evaluation of both serum Klotho/FGF-23 and apelin-13 for detection of diabetic nephropathy

  2023cites this paper
• Metformin Inhibits ROS/TNF-α Axis-Mediated Chronic Kidney Disease Induced by TAA Independent of Leukocyte Infiltration in Association with the Inhibition of Kidney Injury Biomarkers

  2023cites this paper
• Diabetic complications and prospective immunotherapy

  2023cites this paper
• TRAF1 improves cisplatin-induced acute kidney injury via inhibition of inflammation and metabolic disorders.

  2023cites this paper
• A2BAR Antagonism Decreases the Glomerular Expression and Secretion of Chemoattractants for Monocytes and the Pro-Fibrotic M2 Macrophages Polarization during Diabetic Nephropathy

  2023cites this paper
• Single-cell transcriptomics systematically discloses the immune-inflammatory responses of peripheral blood mononuclear cells for diabetic nephropathy

  2023cites this paper